干扰素α治疗期间的血小板减少症。 - Suppr

Suppr

超能文献

Thrombocytopenia during interferon alfa therapy.

作者信息

Hoofnagle J H

机构信息

National Institutes of Health, Bethesda, Md.

出版信息

JAMA. 1991 Aug 14;266(6):849. doi: 10.1001/jama.266.6.849.

DOI:10.1001/jama.266.6.849

PMID:1865526

Abstract

摘要

相似文献

Thrombocytopenia during interferon alfa therapy.干扰素α治疗期间的血小板减少症。

JAMA. 1991 Aug 14;266(6):849. doi: 10.1001/jama.266.6.849.

Immune thrombocytopenia and interferon alfa.免疫性血小板减少症与干扰素α

BMJ. 1988 Dec 17;297(6663):1613. doi: 10.1136/bmj.297.6663.1613-b.

Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.关于：丙型肝炎病毒慢性感染患者接受α干扰素治疗后出现危及生命的严重免疫性血小板减少症

Am J Gastroenterol. 1996 Apr;91(4):821-2.

Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1.

J Viral Hepat. 2004 Sep;11(5):477-8. doi: 10.1111/j.1365-2893.2004.00536.x.

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.

Gastroenterology. 1992 Jun;102(6):2155-60. doi: 10.1016/0016-5085(92)90348-3.

Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.接受干扰素α治疗的慢性病毒性肝炎患者的视网膜病变和结膜下出血

Br J Ophthalmol. 1995 Feb;79(2):150-2. doi: 10.1136/bjo.79.2.150.

Bleeding in immune thrombocytopenic purpura after alpha-interferon.

Lancet. 1990 Feb 24;335(8687):471-2. doi: 10.1016/0140-6736(90)90701-6.

Acute B-lineage lymphoid malignancy after interferon therapy for chronic viral hepatitis.

Blood. 1994 Feb 1;83(3):869-70.

Thrombocytopenic purpura as a manifestation of acute hepatitis A.血小板减少性紫癜作为甲型急性肝炎的一种表现。

J Clin Gastroenterol. 1993 Sep;17(2):166-7. doi: 10.1097/00004836-199309000-00016.

Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial.重组干扰素α-2a长期与短期治疗慢性乙型肝炎患者：一项前瞻性随机治疗试验

Mayo Clin Proc. 1990 Oct;65(10):1330-5. doi: 10.1016/s0025-6196(12)62144-2.

引用本文的文献

Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report.聚乙二醇化干扰素（IFN）-α-2a联合利巴韦林治疗导致肌苷三磷酸酶（ITPA）-CC基因型患者出现严重血小板减少症：一例报告

BMC Res Notes. 2014 Mar 12;7:141. doi: 10.1186/1756-0500-7-141.

Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.接受聚乙二醇干扰素和利巴韦林治疗的埃及慢性丙型肝炎患者血液学副作用的发生率及预测因素

Indian J Gastroenterol. 2013 Sep;32(5):316-23. doi: 10.1007/s12664-013-0336-z. Epub 2013 May 29.

Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.腹腔镜脾切除术联合聚乙二醇干扰素和利巴韦林治疗丙型肝炎病毒肝硬化合并脾功能亢进。

Surg Endosc. 2010 Mar;24(3):680-5. doi: 10.1007/s00464-009-0653-6. Epub 2009 Aug 19.

Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.不同干扰素α单药及联合治疗方案治疗慢性丙型肝炎期间造血功能的抑制

Gut. 2005 Jul;54(7):1014-20. doi: 10.1136/gut.2004.057893.

Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension.腹腔镜脾切除术可逆转丙型肝炎肝硬化和门静脉高压患者的血小板减少症。

J Gastrointest Surg. 2004 Jan;8(1):120-6. doi: 10.1016/j.gassur.2003.10.009.

Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.聚乙二醇干扰素α-2b联合利巴韦林治疗丙型肝炎所致的自身免疫性血小板减少症

Dig Dis Sci. 2002 Mar;47(3):562-3. doi: 10.1023/a:1017964002402.

Risks and benefits of interferon-alpha in the treatment of hepatitis.α干扰素治疗肝炎的风险与益处

Drug Saf. 1995 Nov;13(5):304-16. doi: 10.2165/00002018-199513050-00004.

Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.慢性乙型肝炎干扰素治疗期间短暂性自身免疫性肝炎的发生

Dig Dis Sci. 1995 Aug;40(8):1842-4. doi: 10.1007/BF02212711.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验